All In Biotech

Drug Trial Radar · NCT00134966

A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa

A 39 Week Randomized, Double-Blind, Parallel Group, Multicenter Study to Evaluate the Effect of Fixed Dose Carbidopa/Levodopa/Entacapone 100 mg t.i.d. vs. Immediate Release Carbidopa/Levodopa 25/100 mg (t.i.d.) in Parkinson's Disease Patients Requiring Levodopa

Last checked: Nov 19, 2026Latest source record: May 17, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 493 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

493

Actual

Start

Aug 2005

Primary completion

Sep 2007

Study completion Sep 2007

Sponsor

Lead sponsor
NovartisNovartis (NVS)
Sponsor type
Industry
First posted
Aug 25, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 30 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to achieve approval for the use of carbidopa/levodopa/entacapone in early Parkinson's disease (PD) by demonstrating that when used as initial levodopa therapy in early PD, carbidopa/levodopa/entacapone provides significantly greater symptomatic benefit than immediate release carbidopa/levodopa administered at the same levodopa dosage level of 100 mg three times a day (t.i.d.).

Conditions

  • Parkinson's Disease

Interventions

  • capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Symptom control change from baseline to week 39

Locations

60 sites in 8 countries. Site status is shown where the registry gives one.

  • Barrow Neurology Clinics at St. Joseph's Hosptial & Medical Center

    Phoenix, Arizona

  • Coastal Neurological Medical Group, Inc

    La Jolla, California

  • Neurosearch, Inc.

    Reseda, California

  • University of Florida Health Science Center

    Jacksonville, Florida

  • Mayo Clinic

    Jacksonville, Florida

  • USF Medical Clinic

    Tampa, Florida

  • Springfield Neurology Associates, LLC

    Springfield, Massachusetts

  • Clinical Neuroscience Center

    Southfield, Michigan

  • Melbourne Internal Medicine Associates

    Westlake, Ohio

  • Westmoreland Neurology Associates, Inc.

    Greensburg, Pennsylvania

  • Lankenau Hospital

    Wynnewood, Pennsylvania

  • NeuroHealth

    Warwick, Rhode Island

  • Coastal Neurology, PA

    Beaufort, South Carolina

  • Senior Adults Specialty Research

    Austin, Texas

  • Baylor College of Medicine, Parkinson's Disease Center

    Houston, Texas

  • Neurology Associates

    San Marcos, Texas

  • Blue Ridge Research Center at Roanoke Neurological Center

    Roanoke, Virginia

  • Quebec Memory and Motor Skills Disorders Clinic

    Québec, Canada

  • University of Saskatchewan, Royal University Hospital

    Saskatoon, Canada

  • Heritage Medical Research Clinic

    Calgary, Alberta, Canada

  • Site not named

    Moncton, New Brunswick, Canada

  • Eastern Health Care - Health Sciences Centre, Neurology Department

    HSC Room 5317, 300 Prince Philip Drive, Saint John's, Newfoundland and Labrador, Canada

  • Neurology Division, Health Science Center

    Halifax, Nova Scotia, Canada

  • Cape Breton Regional Hospital, Neurology Department

    Sydney, Nova Scotia, Canada

  • Grand River Hospital

    Kitchener, Ontario, Canada

  • London Health Sciences Center, University Hospital, Rm. A10-026

    London, Ontario, Canada

  • Centre for Movement Disorders

    Markham, Ontario, Canada

  • Parkinson's & Neurodegenerative Disorders Clinic

    Ottawa, Ontario, Canada

  • Ottawa Hospital, Civic Campus

    Ottawa, Ontario, Canada

  • Hiren Desai Medicine Professional Corporation

    Windsor, Ontario, Canada

  • Neuro Rive Sud

    Greenfield Park, Quebec, Canada

  • Montreal General Hospital

    Montreal, Quebec, Canada

  • Unite des Troubles du Mouvement Andre-Barbeau, CHUM-Hotel-Dieu

    Montreal, Quebec, Canada

  • Centre de Recjerche Clinique du CHUS

    Sherbrooke, Quebec, Canada

  • Dr. Felix Veloso Research

    Regina, Saskatchewan, Canada

  • Neurologicka klinika

    Katerinska 12, Praha 2, Czechia

  • FN-Nemocnice Pardubice

    Kyjevska 44, Pardubice, Czechia

  • Neurologická klinika, Univerzita Palackého

    I.P.Pavlova 6, Olomouc, Czechia

  • FN-neurologická klinika

    Alej Svobody 80, Plzeň, Czechia

  • Dep. Of Neurology (Bitan 38, EEG institute)

    Dep. of Neurology, Zerifin, Israel

Showing 40 of 60 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.